Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma — Stella

Recruiting

Back to Melasma (Facial Melasma) trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(1 site)

China

The first Affiliated hospital with Nanjing medical university, Nanjing, Jiangsu

Key details

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Enrollment target

~35 participants

Started

October 2024

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 55 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov